In today's episode, Sian Estdale tells us about her Scientific Affairs team. Sian shares the key areas they focus on and the goals she has for her and her team. She tells us the importance of being a part of the conversation, so listen now and join the discussion ..read more

Join Lucas Rifkin, MD, from Medical Affairs at Covance by Labcorp, and Yoav Peretz, PhD, Global Scientific Director for Flow Cytometry. This week they discuss Multiple Myeloma, focusing on minimal residual disease monitoring with flow cytometry, and a newly validated assay available at Covance by Labcorp ..read more

Join Dr. Heinz Reiske and Dr. Robert Pawlak as they discuss key issues for developing and validating a COVID-19 assay in the field of Genomics including qualitative vs quantitative assays, various limitations in sample types and throughput. Key Takeaways - Differences in molecular testing from serology and antigen detection - Main validation experiments required for CAP-grade validation - Circumstances for high throughput vs. a manual formatmics Podcast edit.mp3 ..read more

Join Dr. Erica Troksa and Katie LaVelle of Covance Central Laboratory Services as they start the COVID-19 assay development discussion, focusing on assay development and validation in the area of immunology including antibody detection, FDA guidance and cytokine and flow assays. Key Takeaways - Clinical benefits of evaluating serology in response to COVID-19 infection - Assay validation approaches across FDA guidance and CAP/CLIA validation - Brief discussion on cytokine and flow assays ..read more

In today's episode, Sian Estdale tells us about her Scientific Affairs team. Sian shares the key areas they focus on and the goals she has for her and her team. She tells us the importance of being a part of the conversation, so listen now and join the discussion ..read more

Join Lucas Rifkin, MD, from Medical Affairs at Covance by Labcorp, and Yoav Peretz, PhD, Global Scientific Director for Flow Cytometry. This week they discuss Multiple Myeloma, focusing on minimal residual disease monitoring with flow cytometry, and a newly validated assay available at Covance by Labcorp ..read more

Join Dr. Heinz Reiske and Dr. Robert Pawlak as they discuss key issues for developing and validating a COVID-19 assay in the field of Genomics including qualitative vs quantitative assays, various limitations in sample types and throughput. Key Takeaways - Differences in molecular testing from serology and antigen detection - Main validation experiments required for CAP-grade validation - Circumstances for high throughput vs. a manual formatmics Podcast edit.mp3 ..read more

Join Dr. Erica Troksa and Katie LaVelle of Covance Central Laboratory Services as they start the COVID-19 assay development discussion, focusing on assay development and validation in the area of immunology including antibody detection, FDA guidance and cytokine and flow assays. Key Takeaways - Clinical benefits of evaluating serology in response to COVID-19 infection - Assay validation approaches across FDA guidance and CAP/CLIA validation - Brief discussion on cytokine and flow assays ..read more

In today's episode, Sian Estdale tells us about her Scientific Affairs team. Sian shares the key areas they focus on and the goals she has for her and her team. She tells us the importance of being a part of the conversation, so listen now and join the discussion ..read more

Join Lucas Rifkin, MD, from Medical Affairs at Covance by Labcorp, and Yoav Peretz, PhD, Global Scientific Director for Flow Cytometry. This week they discuss Multiple Myeloma, focusing on minimal residual disease monitoring with flow cytometry, and a newly validated assay available at Covance by Labcorp ..read more